← Back to all trials
Recruiting
NCT07868640
Blood Samples Were Taken From Patients Undergoing Oncological Treatment in Order to Validate the TST79 Molecular Test
Conditions: Cancer
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 15
Sponsor: Grand Hôpital de Charleroi
Location: Grand Hôpital de Charleroi Charleroi Hainaut
Summary
The pathological anatomy laboratory, which is managed by the IPG, would involve monitoring patients being treated for cancer and receiving care at the GHDC in order to take blood samples from those in whom the presence of plasma ctDNA carrying a mutation in a specific gene is suspected - a mutation detectable by the TST79 test.
Eligibility Criteria
Inclusion Criteria:
* Patients with the following types of cancer may be invited to donate blood as part of one of two approaches:
* lung adenocarcinoma
* colorectal adenocarcinoma
* breast carcinoma
* prostate adenocarcinoma
* clear cell renal cell carcinoma
* GIST/gastrointestinal stromal tumour
* melanoma
* urothelial carcinoma
* endometrial carcinoma
* high-grade ovarian carcinoma
Source: ClinicalTrials.gov (NCT07868640). StuddyBuddy aggregates publicly available trial information.
